000 | 02087 a2200613 4500 | ||
---|---|---|---|
005 | 20250513230515.0 | ||
264 | 0 | _c20010405 | |
008 | 200104s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBarone, F C | |
245 | 0 | 0 |
_aSB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cFeb 2001 |
||
300 |
_a312-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aBody Temperature _xdrug effects |
650 | 0 | 4 |
_aBrain _xpathology |
650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 |
_aHippocampus _xpathology |
650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
650 | 0 | 4 |
_aInflammation _xpathology |
650 | 0 | 4 |
_aIschemic Attack, Transient _xdrug therapy |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
650 | 0 | 4 | _aOrgan Culture Techniques |
650 | 0 | 4 |
_aPyridines _xtherapeutic use |
650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 | _aRats, Inbred SHR |
650 | 0 | 4 | _ap38 Mitogen-Activated Protein Kinases |
700 | 1 | _aIrving, E A | |
700 | 1 | _aRay, A M | |
700 | 1 | _aLee, J C | |
700 | 1 | _aKassis, S | |
700 | 1 | _aKumar, S | |
700 | 1 | _aBadger, A M | |
700 | 1 | _aWhite, R F | |
700 | 1 | _aMcVey, M J | |
700 | 1 | _aLegos, J J | |
700 | 1 | _aErhardt, J A | |
700 | 1 | _aNelson, A H | |
700 | 1 | _aOhlstein, E H | |
700 | 1 | _aHunter, A J | |
700 | 1 | _aWard, K | |
700 | 1 | _aSmith, B R | |
700 | 1 | _aAdams, J L | |
700 | 1 | _aParsons, A A | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 296 _gno. 2 _gp. 312-21 |
|
999 |
_c11100100 _d11100100 |